These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1116868)

  • 1. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
    McLeod B; Baker P; Gewurz H
    Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
    McLeod B; Baker P; Behrends C; Gewurz H
    Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
    McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
    Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.
    Baker PJ; Lint TF; Siegel J; Kies MW; Gewurz H
    Immunology; 1976 Apr; 30(4):467-73. PubMed ID: 818007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.
    McLeod BC; Baker P; Gewurz H
    Int Arch Allergy Appl Immunol; 1974; 47(4):623-32. PubMed ID: 4415956
    [No Abstract]   [Full Text] [Related]  

  • 7. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.
    Goldman JN; Ruddy S; Austen KF
    J Immunol; 1972 Aug; 109(2):353-9. PubMed ID: 4558539
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
    Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
    J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.
    Yamamoto KI; Lint TF; Gewurz H
    J Immunol; 1977 Oct; 119(4):1346-50. PubMed ID: 894040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors.
    Baker PJ; Lint TF; Mortensen RF; Gewurz H
    J Immunol; 1977 Jan; 118(1):198-202. PubMed ID: 830747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.
    Lachmann PJ; Thompson RA
    J Exp Med; 1970 Apr; 131(4):643-57. PubMed ID: 4193935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
    Müller F; Segerling M
    Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of nascent C567 (reactive lysis).
    Goldman JN
    Transplant Proc; 1974 Mar; 6(1):21-5. PubMed ID: 4817055
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipoproteins and C567-INH activity.
    Lint TF; Behrends CL; Gewurz H
    J Immunol; 1977 Sep; 119(3):883-8. PubMed ID: 561124
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A.
    Tomita A; Radike EL; Parker CJ
    J Immunol; 1993 Sep; 151(6):3308-23. PubMed ID: 7690802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.